Total active cases stand at 13,944
coronavirus2 days ago
Pfizer has started an early-stage US trial of an oral Covid-19 antiviral therapy that could be prescribed to patients at the first sign of infection, the company said on Tuesday.
The drugmaker, which developed the first authorised coronavirus vaccine in the US with Germany's BioNTech SA, said the antiviral candidate showed potent activity against SARS-CoV-2, the virus that causes COVID-19, in lab studies.
Pfizer's candidate, named PF-07321332, is a protease inhibitor that prevents the virus from replicating in cells.
Protease inhibitors have been effective at treating other viral pathogens such as HIV and hepatitis C virus, both on their own and in combination with other antivirals, the company said.
Pfizer believes this class of molecules may provide well-tolerated treatments against Covid-19, as currently marketed therapeutics that work on the same lines have not reported safety concerns.
The company is also studying an intravenously administered antiviral candidate in an early-stage trial in hospitalized COVID-19 patients.
"Together, the two (oral and intravenous candidates) have the potential to create an end-to-end treatment paradigm that complements vaccination in cases where disease still occurs," Pfizer's Chief Medical Officer Mikael Dolsten said in a statement.
Pfizer's candidate is behind two other oral antiviral therapies, which are in mid-stage trials – the first being developed by rival Merck & Co with Ridgeback Bio, and a second from Roche Holding and Atea Pharmaceuticals.
Gilead Sciences' remdesivir is currently the only US Food and Drug Administration-approved drug for the treatment of COVID-19.
The FDA has granted an emergency authorization to intravenous therapies from Eli Lilly - bamlanivimab alone and in combination with etesevimab, and a combination therapy from Regeneron.
Total active cases stand at 13,944
coronavirus2 days ago
389,943 infections reported in the Sultanate since the pandemic began
coronavirus2 days ago
Authority issues guidelines for citizens
coronavirus2 days ago
Visitors from outside of the EU allowed to enter with negative Covid test
coronavirus3 days ago
The total doses administered now stand at 24.8 million
coronavirus3 days ago
The Hope Consortium has delivered millions of vaccines from the point of manufacture to the point of immunisation
coronavirus3 days ago
Over 160 million PCR tests have been conducted in the country so far
coronavirus3 days ago
Partners exhibited excellence and professionalism in their cooperation: Major General Ahmed Mohamed Rafie
coronavirus3 days ago